Market Place
Sourcing Support
All News #Library
Biotech
Lantern Pharma, Starlight Therapeutics Clear FDA For STAR-001
27 Mar 2026 //
PHARMIWEB
Lantern Pharma Presents At 7th Glioblastoma Drug Summit
10 Feb 2026 //
BUSINESSWIRE
Lantern Sets Up A.I. Center In India To Boost RADR Platform
12 Jan 2026 //
BUSINESSWIRE
Lantern Pharma Advances LP-184 Trials with Positive Phase 1a Data
03 Dec 2025 //
PHARMIWEB
Lantern Pharma Showcases LP-284 Data At LL&M Congress
28 Oct 2025 //
BUSINESSWIRE
Starlight Gets FDA Clearance for Phase Ib/2a GBM Trial
06 Aug 2025 //
BUSINESSWIRE
Lantern Finishes Enrollment for LP-300 Lung Cancer Trial in Japan
31 Jul 2025 //
BUSINESSWIRE
Lantern Wins EU Patent for AI-Based Cancer Drug LP-284
21 Jul 2025 //
BUSINESSWIRE
Lantern Pharma Debuts AI Tool for Cancer Combo Predictions
15 Jul 2025 //
BUSINESSWIRE
Lantern Unveils AI Module for Precision ADC Development in Cancer
27 Jan 2025 //
BUSINESSWIRE
Oregon, Lantern Launch AI Collaboration On Cancer Metabolism Drug
06 May 2024 //
BUSINESSWIRE
Lantern Pharma Advances Unique ADC Program Across Multiple Solid Tumor Cancers
15 Feb 2024 //
BUSINESSWIRE
Lantern Pharma Announces Publication in Clinical Cancer Research
03 Oct 2023 //
BUSINESSWIRE
Lantern Pharma Leverages AI Platform, RADR®, to Develop ADCs
08 Jun 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.